ANAVX | OAZIX | ANAVX / OAZIX | |
Total Expense Ratio | 0.90 | 0.75 | 120% |
Annual Report Gross Expense Ratio | 0.95 | 0.75 | 127% |
Fund Existence | 11 years | 4 years | - |
Gain YTD | 14.621 | 14.034 | 104% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500000 | 1000000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 65.9M | 13.5B | 0% |
Annual Yield % from dividends | 2.32 | 2.56 | 90% |
Returns for 1 year | 10.97 | 8.31 | 132% |
Returns for 3 years | 24.21 | 29.15 | 83% |
Returns for 5 years | 49.52 | N/A | - |
Returns for 10 years | 9.77 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BIS | 21.02 | 0.74 | +3.65% |
ProShares UltraShort Nasdaq Biotech | |||
RSPG | 72.24 | 0.79 | +1.11% |
Invesco S&P 500® Equal Weight Energy ETF | |||
XOMO | 13.13 | 0.09 | +0.69% |
YieldMax XOM Option Income Strategy ETF | |||
QLTA | 46.85 | -0.02 | -0.04% |
iShares Aaa - A Rated Corporate Bond ETF | |||
NOCT | 50.82 | -0.03 | -0.06% |
Innovator Growth-100 Pwr Buff ETF™ Oct |